<code id='C73A0C838A'></code><style id='C73A0C838A'></style>
    • <acronym id='C73A0C838A'></acronym>
      <center id='C73A0C838A'><center id='C73A0C838A'><tfoot id='C73A0C838A'></tfoot></center><abbr id='C73A0C838A'><dir id='C73A0C838A'><tfoot id='C73A0C838A'></tfoot><noframes id='C73A0C838A'>

    • <optgroup id='C73A0C838A'><strike id='C73A0C838A'><sup id='C73A0C838A'></sup></strike><code id='C73A0C838A'></code></optgroup>
        1. <b id='C73A0C838A'><label id='C73A0C838A'><select id='C73A0C838A'><dt id='C73A0C838A'><span id='C73A0C838A'></span></dt></select></label></b><u id='C73A0C838A'></u>
          <i id='C73A0C838A'><strike id='C73A0C838A'><tt id='C73A0C838A'><pre id='C73A0C838A'></pre></tt></strike></i>

          00:00
          00:00 00:00 LIVE
          buffering
          Replay
          LIVE
          00:00 / 00:00
          LIVE
          CC
          Opacity :
          Share:
          Close

          leisure time

          author:explore    - browse:18
          Alexis Borisy
          Venture capitalist Alexis Borisy Vanessa Leroy for STAT

          EQRx is done, sold for its cash.

          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

          advertisement

          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          hotspot